Problems With 340B? GAO Is Now Gathering Information From Drug Manufacturers
This article was originally published in The Pink Sheet Daily
Executive Summary
The Government Accountability Office has begun interviewing pharmaceutical manufacturers about their experiences with the 340B drug discount program in preparation for a report mandated by the Affordable Care Act.